✦ LIBER ✦

PUK14 CHALLENGES IN ASSESSING COST-EFFECTIVENESS OF THERAPIES FOR DIALYSIS PATIENTS: A CASE STUDY OF SEVELAMER FOR THE TREATMENT OF HYPERPHOSPHATEMIA

✍ Scribed by D Grima; D Mendelssohn; P Airia; E Dunn; L Bernard

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PUK15 THE COST-EFFECTIVENESS OF LANTHANU

✍ S. Vegter; K. Tolley; A. Levin; C.E. Lok; A.R. Morton; S.D. Soroka; M.S. Keith; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PUK6 FESOTERODINE FOR THE TREATMENT OF O

✍ C Prütz; S Snedecor; M Botteman; J Trocio; D Weinstein 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

Cost-Effectiveness of Lanthanum Carbonat

✍ Stefan Vegter; Keith Tolley; Michael S. Keith; Charmaine E. Lok; Steven D. Sorok 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 491 KB

Cost-Effectiveness of Lanthanum Carbonat

✍ Haesuk Park; Karen L. Rascati; Michael S. Keith; Paul Hodgkins; Michael Smyth; D 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 960 KB

152: A Cost-Effectiveness Model of Phosp

✍ Michael Keith; Michael Smyth; Rashad Carlton; Brian Meissner 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 94 KB

PUK18 STAFF TIME AND COSTS FOR ANEMIA MA

✍ MEF Canziani; SR Manfredi; MG Saggia; V Nasciben 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB